Cargando…
Lipoatrophy associated with daily growth hormone injections
SUMMARY: Recombinant human growth hormone therapy (rhGH) has been available since 1985 for a variety of conditions and has expanded the indications for rhGH therapy and the number of patients receiving therapy. The very nature of the therapy exposes individuals to years of injections. There are a nu...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Bioscientifica Ltd
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8495724/ https://www.ncbi.nlm.nih.gov/pubmed/34515656 http://dx.doi.org/10.1530/EDM-21-0087 |